Even if India never should have been in this position, the cost of its being in this position seems manageable. By way of comparison, India spends 6-7 times as

Even if India never should have been in this position, the cost of its being in this position seems manageable. By way of comparison, India spends 6-7 times as much money on its air force as on buying corona vaccines. This isn't a large budget item, not a large problem. There were shortages, but AFAICT those weren't related either to pricing or to patents. The government ordered what it thought necessary, the manufacturer set up production to match that and delivered doses as ordered. Then more was needed and scaling up further took time. Overall, I can't see reason to count the three problems in the headline as big problems for India.